Cargando…
Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarker...
Autores principales: | Salciccia, Stefano, Capriotti, Anna Laura, Laganà, Aldo, Fais, Stefano, Logozzi, Mariantonia, De Berardinis, Ettore, Busetto, Gian Maria, Di Pierro, Giovanni Battista, Ricciuti, Gian Piero, Del Giudice, Francesco, Sciarra, Alessandro, Carroll, Peter R., Cooperberg, Matthew R., Sciarra, Beatrice, Maggi, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122596/ https://www.ncbi.nlm.nih.gov/pubmed/33922033 http://dx.doi.org/10.3390/ijms22094367 |
Ejemplares similares
-
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
por: Salciccia, Stefano, et al.
Publicado: (2020) -
How urinary stone emergencies changed in the time of COVID-19?
por: Flammia, Simone, et al.
Publicado: (2020) -
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance
por: Salciccia, Stefano, et al.
Publicado: (2023) -
Which factors can influence post-operative renal function preservation after nephron-sparing surgery for kidney cancer: a critical review
por: Di Lascio, Giovanni, et al.
Publicado: (2022) -
Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study
por: Logozzi, Mariantonia, et al.
Publicado: (2021)